Identifying a rare neurological condition in children through innovative approaches

Today we’ll be looking at pioneering work that was recently recognised by the European Paediatric Neurology Society (EPNS) and awarded an EPNS Research Prize. Beta-propeller protein-associated neurodegeneration, commonly known as BPAN, is a rare, progressive and life-limiting neurological disorder beginning in infancy or early childhood. Dr Apostolos Papandreou, from University College London, is leading research into treatments for the disorder which could also have positive implications on more common disorders as well. To tell us more, we welcome in this episode also Dr Jean-Pierre Lin, EPNS Board Member and President of the British Paediatric Neurology Association. Discover more on braininnovationdays.eu

There are no comments yet.

Please log in to write the first comment.